Gilbert & Cook’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,827
Closed -$507K 221
2023
Q1
$507K Buy
6,827
+70
+1% +$5.87K 0.09% 96
2022
Q4
$630K Buy
6,757
+101
+2% +$9.75K 0.11% 79
2022
Q3
$644K Buy
6,656
+160
+2% +$15.8K 0.14% 73
2022
Q2
$602K Buy
6,496
+254
+4% +$24.8K 0.11% 76
2022
Q1
$632K Buy
6,242
+399
+7% +$41.9K 0.1% 80
2021
Q4
$603K Sell
5,843
-1,105
-16% -$102K 0.1% 88
2021
Q3
$590K Buy
6,948
+1,309
+23% +$110K 0.11% 82
2021
Q2
$471K Buy
5,639
+240
+4% +$19.7K 0.08% 108
2021
Q1
$406K Buy
5,399
+981
+22% +$71.5K 0.08% 115
2020
Q4
$303K Buy
4,418
+510
+13% +$33.2K 0.07% 134
2020
Q3
$228K Buy
3,908
+385
+11% +$24K 0.05% 136
2020
Q2
$229K Buy
+3,523
New +$222K 0.06% 134

Other funds holding CVS

Gilbert & Cook's CVS Position: Q2 2023 in Review

Gilbert & Cook sold out of CVS Health (CVS) in Q2 2023, closing a stake of 6,827 shares — an estimated $507K sold.

Gilbert & Cook first reported a position in CVS in Q2 2020 and held it in 12 quarters. The position peaked at $644K in Q3 2022. 2,203 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

  • Gilbert & Cook reported no remaining CVS Health position as of Q2 2023 after selling out during the quarter.
  • Gilbert & Cook sold 6,827 CVS Health shares in Q2 2023, an estimated $507K.
  • Gilbert & Cook first reported a position in CVS Health in Q2 2020 and held it in 12 quarters.
  • Gilbert & Cook's CVS Health position peaked at $644K in Q3 2022.
  • 2,203 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on Gilbert & Cook's 13F filing for Q2 2023, filed 14 Aug 2023.